Cargando…
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
We have previously shown that aberrant promoter methylation of ZNF331 is a potential biomarker for colorectal cancer detection with high sensitivity (71%) and specificity (98%). This finding was recently confirmed by others, and it was additionally suggested that promoter methylation of ZNF331 was a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975481/ https://www.ncbi.nlm.nih.gov/pubmed/29854011 http://dx.doi.org/10.1186/s13148-018-0503-2 |